Comparison of circulating tumor DNA assays for Molecular Residual Disease detection in early-stage triple negative breast cancer.

Maria Coakley Guillermo Villacampa Prithika Sritharan Claire Swift Kathryn Dunne Lucy Suzanne Kilburn Katie Goddard Christodoulos Pipinikas Patricia Rojas Warren Emmett Peter S Hall Catherine Harper-Wynne Tamas Hickish Iain R J Macpherson Alicia F C Okines Andrew M Wardley Duncan A Wheatley Simon H Waters Carlo Palmieri Matthew C Winter Rosalind J Cutts Isaac Garcia-Murillas Judith M Bliss Nicholas C Turner

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)

Personalized multi-mutation sequencing assays have potential clinically important improvements in clinical outcome in the early detection of MRD.

Keyphrases